Creo S2ai
Payments companies reported to CMS as associated with Creo S2ai. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Creo S2ai, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Creo S2ai
These are the largest totals companies reported as associated with Creo S2ai. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adam Back | Spartanburg, SC | Neurological Surgery | $11,188.69 |
| Jason Liauw | Laguna Hills, CA | Neurological Surgery | $11,188.69 |
| Paul Mcafee | Baltimore, MD | Orthopaedic Surgery of The Spine | $11,156.53 |
| Ryan Kretzer | Tucson, AZ | Neurological Surgery | $11,150.53 |
| Andrew Pugely | Iowa City, IA | Orthopaedic Surgery of The Spine | $10,851.20 |
| Virgilio Matheus | Orlando, FL | Neurological Surgery | $420.28 |
| Dustin Hatefi | San Diego, CA | Neurological Surgery | $147.63 |
| Michael Gelsomino | Athens, GA | Neurological Surgery | $147.63 |
| Anthony Velott | Westminster, MD | Sports Medicine (Orthopaedic Surgery) | $130.55 |
| James Nace | Baltimore, MD | Adult Reconstructive Orthopaedic Surgery | $130.54 |
Prescribed Creo S2ai?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.